These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 19555698)
1. Sustained delivery of FGF-1 increases vascular density in comparison to bolus administration. Moya ML; Lucas S; Francis-Sedlak M; Liu X; Garfinkel MR; Huang JJ; Cheng MH; Opara EC; Brey EM Microvasc Res; 2009 Sep; 78(2):142-7. PubMed ID: 19555698 [TBL] [Abstract][Full Text] [Related]
2. FGF-1 delivery from multilayer alginate microbeads stimulates a rapid and persistent increase in vascular density. Khanna O; Huang JJ; Moya ML; Wu CW; Cheng MH; Opara EC; Brey EM Microvasc Res; 2013 Nov; 90():23-9. PubMed ID: 23978335 [TBL] [Abstract][Full Text] [Related]
3. The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering. Moya ML; Cheng MH; Huang JJ; Francis-Sedlak ME; Kao SW; Opara EC; Brey EM Biomaterials; 2010 Apr; 31(10):2816-26. PubMed ID: 20080298 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-1 (FGF-1) loaded microbeads enhance local capillary neovascularization. Moya ML; Garfinkel MR; Liu X; Lucas S; Opara EC; Greisler HP; Brey EM J Surg Res; 2010 May; 160(2):208-12. PubMed ID: 19959194 [TBL] [Abstract][Full Text] [Related]
5. New alginate microcapsule system for angiogenic protein delivery and immunoisolation of islets for transplantation in the rat omentum pouch. McQuilling JP; Arenas-Herrera J; Childers C; Pareta RA; Khanna O; Jiang B; Brey EM; Farney AC; Opara EC Transplant Proc; 2011 Nov; 43(9):3262-4. PubMed ID: 22099771 [TBL] [Abstract][Full Text] [Related]
6. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres. Layman H; Li X; Nagar E; Vial X; Pham SM; Andreopoulos FM J Biomater Sci Polym Ed; 2012; 23(1-4):185-206. PubMed ID: 21192837 [TBL] [Abstract][Full Text] [Related]
7. Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass. Keshaw H; Forbes A; Day RM Biomaterials; 2005 Jul; 26(19):4171-9. PubMed ID: 15664644 [TBL] [Abstract][Full Text] [Related]
8. Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro. Downs EC; Robertson NE; Riss TL; Plunkett ML J Cell Physiol; 1992 Aug; 152(2):422-9. PubMed ID: 1379248 [TBL] [Abstract][Full Text] [Related]
9. MRI study of cryoinjury infarction in pig hearts: i. Effects of intrapericardial delivery of bFGF/VEGF embedded in alginate beads. Yang Y; Gruwel ML; Dreessen de Gervai P; Sun J; Jilkina O; Gussakovsky E; Kupriyanov V NMR Biomed; 2012 Jan; 25(1):177-88. PubMed ID: 21960023 [TBL] [Abstract][Full Text] [Related]
10. Site-specific delivery of acidic fibroblast growth factor stimulates angiogenic and osteogenic responses in vivo. Kelpke SS; Zinn KR; Rue LW; Thompson JA J Biomed Mater Res A; 2004 Nov; 71(2):316-25. PubMed ID: 15376268 [TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-2-overexpressing myoblasts encapsulated in alginate spheres increase proliferation, reduce apoptosis, induce adipogenesis, and enhance regeneration following skeletal muscle injury in rats. Stratos I; Madry H; Rotter R; Weimer A; Graff J; Cucchiarini M; Mittlmeier T; Vollmar B Tissue Eng Part A; 2011 Nov; 17(21-22):2867-77. PubMed ID: 21815803 [TBL] [Abstract][Full Text] [Related]
13. Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model. Layman H; Sacasa M; Murphy AE; Murphy AM; Pham SM; Andreopoulos FM Acta Biomater; 2009 Jan; 5(1):230-9. PubMed ID: 18713669 [TBL] [Abstract][Full Text] [Related]
14. The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. Ruvinov E; Leor J; Cohen S Biomaterials; 2010 Jun; 31(16):4573-82. PubMed ID: 20206988 [TBL] [Abstract][Full Text] [Related]
15. Acceleration of surgical angiogenesis in necrotic bone with a single injection of fibroblast growth factor-2 (FGF-2). Nakamae A; Sunagawa T; Ishida O; Suzuki O; Yasunaga Y; Hachisuka H; Ochi M J Orthop Res; 2004 May; 22(3):509-13. PubMed ID: 15099628 [TBL] [Abstract][Full Text] [Related]
17. The distribution of the growth factors FGF-2 and VEGF, and their receptors, in growing red deer antler. Lai AK; Hou WL; Verdon DJ; Nicholson LF; Barling PM Tissue Cell; 2007 Feb; 39(1):35-46. PubMed ID: 17316726 [TBL] [Abstract][Full Text] [Related]
18. Glypican-1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis. Monteforte AJ; Lam B; Das S; Mukhopadhyay S; Wright CS; Martin PE; Dunn AK; Baker AB Biomaterials; 2016 Jul; 94():45-56. PubMed ID: 27101205 [TBL] [Abstract][Full Text] [Related]
19. VEGF-loaded microsphere patch for local protein delivery to the ischemic heart. Rodness J; Mihic A; Miyagi Y; Wu J; Weisel RD; Li RK Acta Biomater; 2016 Nov; 45():169-181. PubMed ID: 27619839 [TBL] [Abstract][Full Text] [Related]
20. The role of basic-fibroblast growth factor (b-FGF) in cyclosporine-induced nephrotoxicity. Efthimiadou A; Lambropoulou M; Pagonopoulou O; Vakalopoulos I; Papadopoulos N; Nikolettos N In Vivo; 2006; 20(2):265-9. PubMed ID: 16634529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]